“We started working with the RNA team when we realized that the large branded firm that we were working with needed too much hand holding to understand our investments and the royalty industry. We switched to RNA because they understand the sector, are responsive and efficient, and are in the flow of the biopharma ecosystem.”
“The RNA team has helped us with tax and financial reporting-oriented valuation work. Its nice to work with a firm that not only understands the intricacies of reporting requirements but actually understands the drug development business.”
“I’ve worked with the RNA team for over a decade across my current and previous companies. They are our go to valuation firm for valuation because they know the industry, are responsive and understand the nuances that drive transactions just as much as accounting.”
“I’ve worked with the RNA team on a number of valuation matters, large and small. These guys know their stuff. Whether using them to assist with large licensing transaction negotiations to simple tax and financial reporting work, they understand and they deliver.”
Enter your email address below to receive updates from RNA Advisors.